Thymalin
Thymalin is a thymus-derived dipeptide complex (Glu-Trp) developed in Russia for immune restoration, particularly in aging populations. It modulates T-cell differentiation, cytokine balance, and has been studied for its interactions with the pineal gland via the pineal-thymus axis.
Thymalin is a synthetic dipeptide (L-glutamyl-L-tryptophan) originally isolated from bovine thymus tissue by Vladimir Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation and Gerontology in the 1970s. It belongs to a class of short bioregulatory peptides (cytomedins) developed in the Soviet Union for clinical use in immune reconstitution.
Overview
Thymalin was one of the first bioregulatory peptides developed under the Soviet cytomedins program, which sought to identify short peptides capable of restoring organ-specific function. Extracted originally from calf thymus and later produced synthetically, Thymalin has been used clinically in Russia and CIS countries for over 30 years, primarily for immune restoration in elderly and immunocompromised patients. It has been registered as a pharmaceutical product in Russia and is administered as a course of intramuscular injections, typically 5-10 mg daily for 5-10 days.
The peptide's significance extends beyond simple immunomodulation. Research by Khavinson and Anisimov demonstrated that Thymalin, in combination with the pineal peptide Epithalon, could extend lifespan in animal models, suggesting a functional link between the thymus and the pineal gland in aging regulation.
Mechanism of Action
Thymalin acts primarily through modulation of T-lymphocyte differentiation and cytokine production. Its proposed mechanisms include:
T-cell maturation: Thymalin promotes the differentiation of immature T-cell precursors (thymocytes) into mature CD4+ and CD8+ T lymphocytes, restoring the balance between helper and cytotoxic T-cell populations that deteriorates with thymic involution during aging.
Cytokine regulation: The peptide modulates the production of key cytokines including IL-2, interferon-gamma, and TNF-alpha, shifting the immune response toward a more balanced Th1/Th2 profile. This is particularly relevant in elderly individuals who exhibit chronic low-grade inflammation (inflammaging).
Pineal-thymus axis: Thymalin has been shown to influence melatonin production and interact with the pineal gland through a bidirectional neuroendocrine circuit. This axis is believed to play a role in the circadian regulation of immune function and in the aging process itself.
Antioxidant effects: Thymalin enhances the activity of antioxidant enzymes including superoxide dismutase (SOD) and catalase, potentially reducing oxidative damage to immune cells.
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Thymic Involution and Aging
Research into age-related thymic atrophy has identified Thymalin as a potential intervention for reversing the functional decline of the thymus. Studies in aged mice showed that Thymalin treatment partially restored thymic architecture, increased thymopoiesis, and improved the diversity of the peripheral T-cell receptor repertoire. These findings support the concept that short peptide bioregulators can counteract aspects of immune aging.
Cancer Adjunct Therapy
In a series of studies on cancer patients undergoing chemotherapy and radiation, Thymalin administration was associated with improved immune parameters, reduced infection rates, and better tolerance of cytotoxic treatments. A study in patients with gastric and colorectal cancers demonstrated that Thymalin supplementation during chemotherapy preserved lymphocyte counts and NK cell activity compared to controls (Khavinson et al., 2002).
Pineal-Thymus Axis and Longevity
The interaction between Thymalin and Epithalon has been a central focus of Khavinson's longevity research. In a landmark study, elderly patients (over 60 years) received annual courses of Thymalin and Epithalon for 6 years. The treatment group showed a 4.1-fold reduction in mortality compared to controls, along with improvements in cardiovascular, immune, endocrine, and neurological function (Khavinson et al., 2003). Animal studies in aging rats confirmed that combined Thymalin-Epithalon treatment extended mean lifespan by approximately 30%.
Immune Reconstitution in Elderly Patients
Clinical studies conducted in Russia examined Thymalin administration in elderly patients (60-80 years) with age-related immunodeficiency. Patients received 10 mg intramuscularly daily for 5-10 days. Results showed significant increases in CD3+, CD4+, and CD8+ T-cell counts, improved lymphocyte proliferative responses to mitogens, and normalization of the CD4/CD8 ratio. Effects were sustained for 3-6 months following a single treatment course (Khavinson & Morozov, 2003).
Safety Profile
Thymalin has been used clinically in Russia for over 30 years with a generally favorable safety profile. Reported side effects are rare and typically mild, including transient injection site reactions and occasional low-grade fever. No significant adverse events have been documented in the published literature. However, formal safety data meeting Western regulatory standards (Phase I-III clinical trials with GMP-produced material) are not available. Thymalin should be used with caution in patients with autoimmune conditions, as immune stimulation could theoretically exacerbate autoimmune pathology.
Pharmacokinetic Profile
- Half-life
- Not established (complex mixture); effects persist for weeks
Quick Start
- Typical Dose
- 10mg per injection
- Frequency
- Daily for 5-10 days, then break
- Route
- Intramuscular injection
- Cycle Length
- 5-10 day cycles (short bioregulator protocol)
- Storage
- Reconstituted: 2-8°C refrigerated
Molecular Structure
- Formula
- C3H7NO3
- Weight
- 333.34 Da
- CAS
- 69440-38-6
- PubChem CID
- 6857552
- Exact Mass
- 105.0426 Da
- LogP
- -2.4
- TPSA
- 88 Ų
- H-Bond Donors
- 2
- H-Bond Acceptors
- 3
- Rotatable Bonds
- 1
- Complexity
- 67
Identifiers (SMILES, InChI)
InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)
MTCFGRXMJLQNBG-UHFFFAOYSA-NResearch Indications
Immune Support
Stimulates T-lymphocyte differentiation and activity for comprehensive immune system restoration.
Accelerates recovery of lymphocyte populations including CD4+, CD3+HLA-DR+, B-cells, and NK-cells.
2.0-2.4 fold reduction in acute respiratory disease incidence in elderly patients.
Longevity
Clinical studies showed 2.0-2.1 fold mortality reduction over 6-8 years in treated elderly.
Normalizes basic body functions and improves cardiovascular, endocrine, immune, and nervous systems.
When combined with Epithalamin for 6 years, mortality decreased 4.1 times vs control.
Therapeutic Applications
Faster reversal of lymphopenia and immune marker recovery in severe COVID-19 patients.
Tumor growth arrest and regression observed in over half of animals in sarcoma studies.
Normalizes thymus function during aging process.
Research Protocols
subcutaneous Injection
Administered via intramuscular or subcutaneous injection in short 5-10 day cycles. Often combined with other bioregulators like Epitalon or Vilon for enhanced systemic effects. Practically no side effects, safe for elderly populations.
| Goal | Dose | Frequency | Duration |
|---|---|---|---|
| Immune restoration | 10 mg | Daily | —(Route: IM or SubQ) |
| Standard cycle | 10 mg | Daily for 5-10 days | —(Route: IM or SubQ) |
| Maintenance | 10 mg | 1-2x yearly cycles | —(Route: IM or SubQ) |
| With Epithalamin | 10 mg each | Annual cycles | —(Route: IM or SubQ) |
Reconstitution Guide (mg vial + mL BAC water)
- Clean work area and hands thoroughly
- Calculate required water volume
- Draw water into syringe
- Inject slowly down vial side
- Gently swirl until dissolved (never shake)
- Store in refrigerator
Interactions
Peptide Interactions
Research by Khavinson and Anisimov demonstrated that Thymalin, in combination with the pineal peptide Epithalon, could extend lifespan in animal models, suggesting a functional link between the thymus and the pineal gland in aging regulation.
What to Expect
What to Expect
Initial immune modulation begins
T-cell activation and differentiation enhanced
Improved immune markers on blood tests
Reduced illness frequency
Geroprotective benefits with annual cycles
Safety Profile
Common Side Effects
- Injection site reactions (mild)
- Practically no side effects reported
Contraindications
- Autoimmune diseases (use with caution)
- Organ transplant recipients (immunosuppression needed)
- Pregnancy or breastfeeding
- Known hypersensitivity
Discontinue If
- Signs of allergic reaction
- Unusual immune responses
Quality Indicators
What to look for
- White to off-white lyophilized powder
- Clear solution after reconstitution
- Intact vacuum seal
Caution
- Slight clumping that dissolves easily
Red flags
- Discolored powder
- Cloudy or particulate solution
- Broken seal
Frequently Asked Questions
References (8)
- [7]Anisimov VN et al Effect of Epithalon on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice Biogerontology (2001)
- [1]The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity (2021)
- [3]Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients (2021)
- [5]Khavinson VKh et al Effects of thymalin and epithalon on immunity in cancer patients Bull Exp Biol Med (2002)
- [6]Khavinson VKh, Morozov VG Geroprotective effect of thymalin and epithalon Bull Exp Biol Med (2003)
- [8]Khavinson VKh Peptides and Ageing Neuro Endocrinol Lett (2002)
- [2]
- [4]
Testagen
Testagen is a complex peptide bioregulator preparation targeting testicular tissue, developed at the St. Petersburg Institute of Bioregulation and Gerontology for research in male reproductive aging, testosterone regulation, and spermatogenesis. It is part of the Cytomed line of tissue-specific peptide bioregulators.
Thymopentin
Thymopentin (TP-5) is a synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr) corresponding to residues 32-36 of thymopoietin, the active site responsible for T-cell differentiation. It is studied for immunodeficiency, HIV adjunct therapy, and autoimmune disease management.